ADARx Pharmaceuticals, Inc.
NASDAQ:ADRXBiotechnology
Healthcare
$13.82 +0.73%
+$0.13 today
- Market cap
- $1.53B
- Beta
- 0.00
52W Low $16.64High $23.21
Volume 0.70M
Average 1.06M
ADRX EBITDA Margin
EBITDA as a percentage of revenue.
No reported EBITDA Margin figures are available to summarize.
EBITDA Margin history
Percent of revenue · from the income statement
No EBITDA Margin data reported for this period type.
EBITDA Margin vs competitors
How ADRX compares with its peers on the latest reported figures
ADRX Competitors Peer median
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | -120.0% | +290.8 pp | +619.2 pp | |
| LTM Mar 2026 | -148.9% | -100.7 pp | -100.7 pp | |
| LTM Mar 2026 | -243.2% | -144.4 pp | +3681.3 pp | |
| LTM Mar 2026 | -319.0% | -184.3 pp | +1328.5 pp | |
| FY2025 | -410.9% | — | — | |
| LTM Mar 2026 | -511.5% | -539.6 pp | +799.5 pp | |
| LTM Mar 2026 | -4732.2% | +354.4 pp | — | |
| LTM Mar 2026 | -8478.5% | — | -15524.4 pp | |
ADRXADARx Pharmaceuticals, Inc. | — | — | — | — |
| FY2025 | — | — | — | |
| Peer median (excluding ADRX) | -365.0% | -122.5 pp | +709.4 pp | |
Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Currency unavailable
ADARx Pharmaceuticals, Inc.
NASDAQ:ADRX
Intrinsic Alpha fair value
Locked
Current Price
$13.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.